ElevenLabs authorizes $300 million secondary to double valuation to $22 billion

ElevenLabs, the New York- and London-based startup that builds ultra-realistic synthetic voices, announced a $300 million tender offer that lets employees sell a slice of their vested equity at a $22 billion valuation. The move doubles the $11 billion price tag the company carried after a $500 million raise in February and follows a $100 million secondary transaction at a $6.6 billion valuation in September 2025.

The latest offering was co-led by Wellington and T. Rowe Price, two institutional investors that specialize in backing private companies with the intention of holding the stock through a future public listing. By purchasing shares directly from staff, the investors provide liquidity without forcing a full exit, while the employees gain immediate cash without waiting for an IPO or acquisition.

ElevenLabs, founded in 2022, has quickly become known for its ability to generate human-like speech and sound effects, a capability that has attracted a broad customer base across media, gaming and enterprise applications. The company’s rapid rise to a $22 billion valuation places it among the most valuable private tech firms in Europe, despite its dual headquarters in the United States and United Kingdom.

The tender is the second secondary transaction the four-year-old has authorized for its workforce. The first, a $100 million tender in late 2025, valued the company at $6.6 billion. By offering a larger pool of capital this time, ElevenLabs signals confidence in its growth trajectory and a willingness to use equity liquidity as a retention tool. In a competitive AI talent market, giving staff a path to cash out can reduce turnover risk and keep key engineers and researchers from jumping to rival firms.

Industry observers note that the practice of granting employee liquidity through secondary sales is gaining traction among fast-growing AI startups. As valuations soar and IPO windows narrow, founders and investors are turning to tender offers to reward early hires while preserving the company’s capital structure. The involvement of long-term institutional players like Wellington and T. Rowe Price also suggests that the market expects ElevenLabs to eventually list, with these investors planning to hold the stock post-IPO.

In a recent interview with TechCrunch, co-founder and CEO Mati Staniszewski discussed the company’s product roadmap and the strategic rationale behind the tender, though specific quotes were not released. He emphasized that the liquidity event aligns with ElevenLabs’ broader mission to attract and retain top talent as it scales its voice-generation platform.

Looking ahead, the $300 million infusion provides employees with immediate financial upside while keeping the company fully funded for product development and market expansion. Analysts will watch how the secondary impacts employee morale, hiring, and the timing of a potential public offering. For founders in the AI space, ElevenLabs’ approach underscores a growing playbook: use secondary markets to reward early contributors without diluting the company’s long-term capital plan.